Contract Research Organisation

Your partner in lateral flow test development

Contract Research Services
Innovate To Care

About us

Our Diagnostic Development Process

We support every stage of diagnostic development, from initial research to launch. Engaging us early, in Phase 0 and Phase I, ensures a strong foundation—helping to refine concepts, assess feasibility, and accelerate progress through later stages.

Phases 0 through 5 at GADx

How we help

End-to-end diagnostic development

From feasibility to launch, we guide you through every phase of diagnostic development.
Explore our process

Assay & reagent development

Custom lateral flow solutions, from reagent selection to multiplexing and result interpretation.
Learn more

Reagent analysis & verification

Ensure your reagents meet the highest standards for purity, specificity, and stability.
Refine your reagents

Device development & prototyping

Innovative assay design, housing development, and rapid prototyping to optimize performance.
Find out more

Clinical evaluation & validation testing

Ensuring assay performance, stability, and compliance with regulatory and market requirements.
Validate your assay

Who we work with and support

Supporting diagnostic companies, pharma, & global health funders with tailored contract research services.
Refine your reagents

Get In Touch

Latest News

By Dr Andrew Wheeler

What is a lateral flow immunoassay?

Lateral flow immunoassays, or rapid tests, are simple yet powerful tools used in diagnostics. This article breaks down how they work, what they’re made of, and how they’re developed.…
DIATROPIX diagnostic manufacturing site in Mbao, Senegal
By GADx Team

Advancing Regional Diagnostics: GADx at DIATROPIX Launch

On December 12, 2024, the Institut Pasteur de Dakar (IPD) celebrated its centenary by marking a major milestone in African healthcare innovation: the inauguration of the expanded DIATROPIX diagnostic…
By GADx Team

Driving Diagnostic Innovation in Uganda – HOLICARE

Respiratory Tract Infections (RTIs) are one of the world’s deadliest health threats, hitting the hardest in places where access to healthcare is limited. The HOLICARE project is tackling this…
More news